Doctors often use different methods to help people manage chronic pain. One common approach is prescribing opioid painkillers. These medicines can be very effective, but they also come with serious ...
New research reveals how CBD and THC interact with brain receptors, unlocking potential for safer cannabis-based treatments.
Scientists reveal how CBD could help ease chronic pain, anxiety, and mood disorders. Researchers have uncovered a potential ...
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...
Despite an increase in the use of medication for opioid use disorder in older adults from 2017 to 2022, disparities persist; ...
Most states allow some form of "medical marijuana." It is especially popular with pain patients, many of whom do not have ...
Headaches and migraine, including mild tension headaches, are linked to an increased risk of suicide, according to new ...
A new non-opioid painkiller, suzetrigine, has just been approved by the US drug regulator, the FDA. It is the first ...
Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
As shares of Boston-based Vertex shot higher on the news of its non-opioid pill, Journavx, we took a look at investment in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback